Metastatic Glucagonoma transforming to Insulinoma following Chemotherapy

Scottish Medical Journal

Volumn 52, Issue 1, 2007, Pages 55-

  Iqbal, N ^a   Byard, A ^a   Singh, B M ^a   Buch, H N ^a  

^a NEW CROSS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866168289     PISSN: 00369330     EISSN: 20456441     Source Type: Journal    
DOI: 10.1258/rsmsmj.52.1.55g     Document Type: Article

References (10)

1. Wynick D, Williams SJ, Bloom SR. Symptomatic secondary hormone syndromes in patients with established malignant pancreatic endocrine tumours. N Engl J Med 1988; 319(10): 605–07.
2. Lips CJM, van der Sluys Veer J, van der Donk JA, van Dam RH. Common precursor molecule as origin for the ectopic hormone producing tumour syndrome. Lancet 1978; 1: 16–8.
3. Baylin SB, Mendelsohn G. Ectopic (inappropriate) hormone production by tumours: mechanisms involved and the biological and clinical implications. Endocr Rev 1980; 1: 45–77.
4. Ohneda A, Otsuki M, Fujiya H, Yaginuma N et al. A malignant insulinoma transformed into a glucagonoma syndrome. Diabetes 1979; 28(11): 962–69.
5. Leichter SB. Clinical and metabolic aspects of glucagonoma. Medicine 1980; 59(2): 100–13.
6. Wermers RA, Fatourechi V, Kvols LK. Clinical Spectrum of Hyperglucagonemia associated with malignant neuroendocrine tumours. Mayo Clinic Proceedings 1996; 71(11): 1030–38.
7. Shi W, Johnston CF, Buchanan KD, Larkin C et al. Localization of neuroendocrine tumours with [111ln] DTPA-octreotide scintigraphy (Octreoscan): a comparative study with CT and MR imaging QJM 1998; 91(4): 295–301.
8. D'Arcangues CM, Awoke S, Lawrence GD. Metastatic insulinoma with long survival and glucagonoma syndrome. Ann Intern Med 1984; 100(2): 233–35.
9. Wermers RA, Fatourechi V, Wynne AG, Kvols LK, Lloyd RV. The glucagonoma syndrome: clinical and pathologic features in 21 patients. Medicine 1996; 75(2): 53–63.
10. Grama D, Eriksson B, Matersson H, Cedermark B et al. Clinical characteristics, treatment and survival in patients with pancreatic tumours causing hormonal syndromes. World J Surg 1992; 16(4): 632–9.